Tony Reiman, University of New Brunswick

Research

Assay Biobanking Biomarkers Cancer Trials Mentee Myeloma Oncology Patient Engagement

Latest papers

Synonymous Variants of Potential Significance Identified by a 52-Gene Clinical Sequencing Panel in Non-Small Cell Lung Cancer.
Genes, chromosomes & cancer · 2026 · senior author
Identification of Driver Mutations and Risk Stratification in Lung Adenocarcinoma via Liquid Biopsy.
Cancers · 2025
Use of an Integrated Knowledge Translation Approach to Develop an Electronic Patient-Reported Outcome System for Cancer Rehabilitation: Tutorial
JMIR Cancer · 2025

All 25 publications

Latest funding

Exosomal miRNA Profiling for Molecular Classification of Resorptive Bone Disease Progression
CIHR · 2017 · Supervisor
$5,000
CIHR SPOR Mentorship Chair in Innovative Cancer Clinical Trials
CIHR · 2016 · Nominated PI
$500,000

All 2 grants and awards

25 publications.

01

Synonymous Variants of Potential Significance Identified by a 52-Gene Clinical Sequencing Panel in Non-Small Cell Lung Cancer.

Varty K, MacLean L, Itani D, Hossain M, Acar C, Michael J, Daigle-Maloney T, Thompson R, Johnston B, Russell C, Boudreau JE, Gaston D, Reiman T

Genes, chromosomes & cancer2026Senior author

DOI: 10.1002/gcc.70111 PMID: 41711155

02

Identification of Driver Mutations and Risk Stratification in Lung Adenocarcinoma via Liquid Biopsy.

Pathak GP, Shah R, Reiman T, Wallace A, Carter MD, Snow S, Fris J, Xu Z

Cancers2025

DOI: 10.3390/cancers17081340 PMID: 40282516

03

Use of an Integrated Knowledge Translation Approach to Develop an Electronic Patient-Reported Outcome System for Cancer Rehabilitation: Tutorial

Lopez C, Neil-Sztramko SE, Campbell KL, Langelier DM, Truong T, Gavrylyuk Y, Nyakairu P, Parente L, Durand A, Bender JL

JMIR Cancer2025

DOI: 10.2196/74123

04

Chasing cancer: does the social-to-medical spending ratio relate to cancer incidence and mortality in Canadian provinces? A retrospective cohort study.

MacLellan C, Kershaw P, Kneebone RD, McLaren L, Reiman T, Urquhart R, Dutton DJ

BMJ public health2024

DOI: 10.1136/bmjph-2023-000858 PMID: 40018099

05

TAZ downregulated ANXA1 expression to modulate myeloma cell interactions with bone marrow mesenchymal stromal cells.

Abegunde SO, Grieve S, Reiman T

Experimental hematology2024Senior author

DOI: 10.1016/j.exphem.2024.104282 PMID: 39032857

06

Use of implementation mapping to develop a multifaceted implementation strategy for an electronic prospective surveillance model for cancer rehabilitation

Lopez CJ, Neil-Sztramko SE, Tanyoas M, Campbell KL, Bender JL, Strudwick G, Langelier DM, Reiman T, Greenland J, Jones JM

Implementation Science Communications20246 citations

DOI: 10.1186/s43058-024-00650-4

07

Implementation of an electronic prospective surveillance model for cancer rehabilitation: a mixed methods study protocol

Lopez C, Neil-Sztramko SE, Campbell KL, Langelier DM, Strudwick G, Bender JL, Greenland J, Reiman T, Jones JM, Team CCR

BMJ Open20241 citations

DOI: 10.1136/bmjopen-2024-090449

08

Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis.

Dimopoulos MA, Moreau P, Augustson B, Castro N, Pika T, Delimpasi S, De la Rubia J, Maiolino A, Reiman T, Martinez-Lopez J, Martin T, Mikhael J, Yong K, Risse ML, Asset G, Marion S, Hajek R

American journal of hematology2023

DOI: 10.1002/ajh.26602 PMID: 35604280

09

MST1 downregulates TAZ tumor suppressor protein in multiple myeloma and is a potential therapeutic target.

Abegunde SO, Grieve S, Alfarra H, Reiman T

Experimental hematology2023Senior author

DOI: 10.1016/j.exphem.2023.04.004 PMID: 37137439

10

TAZ upregulates MIR-224 to inhibit oxidative stress response in multiple myeloma.

Abegunde SO, Grieve S, Reiman T

Cancer reports (Hoboken, N.J.)2023Senior author

DOI: 10.1002/cnr2.1879 PMID: 37539777

Exosomal miRNA Profiling for Molecular Classification of Resorptive Bone Disease Progression

SupervisorCIHR2017Undergraduate: Summer Studentship Award - Institute Community Support

Principal investigators: Sarty, Kathleena I

Keywords: Biobank; Biomarkers; Exosomes; Mirna; Mirna Pcr Array; Multiple Myeloma; Qpcr; Resorptive Bone Disease

$5,000

CIHR SPOR Mentorship Chair in Innovative Cancer Clinical Trials

Nominated PICIHR2016SPOR Mentorship Chair in Innovative Clinical Trials

Principal investigators: Reiman, Tony

Keywords: Assay; Biobanking; Biomarkers; Cancer Trials; Mentee; Myeloma; Oncology; Patient Engagement

$500,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Co-authors at University of New Brunswick, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Gillian Strudwick

Institute of Health Policy, Management, and Evaluation

3 shared papers, latest 2025

Sarah Neil-Sztramko

Health Research Methods, Evidence, and Impact

3 shared papers, latest 2025

Eva Grunfeld

Department of Family and Community Medicine

2 shared papers, latest 2019

Audrey Durand

Family Medicine and Emergency Medicine

1 shared papers, latest 2025

Arleigh McCurdy

Department of Medicine

1 shared papers, latest 2021

Martha Louzada

Department of Epidemiology and Biostatistics

1 shared papers, latest 2021

Thomas Pulinilkunnil

Biochemistry and Molecular Biology

1 shared papers, latest 2021

Kevin Imrie

Critical Care Medicine

1 shared papers, latest 2019

Paul Kershaw

School of Population and Public Health

1 shared papers, latest 2024

David Lebrun

Pathology and Molecular Medicine

1 shared papers, latest 2017

Lindsay Mclaren

Community Health Sciences

1 shared papers, latest 2024

David Spaner

Cancer and Cell Biology

1 shared papers, latest 2019

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student: Assay Dear Professor Reiman, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Synonymous Variants of Potential Significance Identified by a 52-Gene Clinical Sequencing Panel in Non-Small Cell Lung Cancer." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Tony Reiman

Research

Latest papers

Latest funding

Synonymous Variants of Potential Significance Identified by a 52-Gene Clinical Sequencing Panel in Non-Small Cell Lung Cancer.

Identification of Driver Mutations and Risk Stratification in Lung Adenocarcinoma via Liquid Biopsy.

Use of an Integrated Knowledge Translation Approach to Develop an Electronic Patient-Reported Outcome System for Cancer Rehabilitation: Tutorial

Chasing cancer: does the social-to-medical spending ratio relate to cancer incidence and mortality in Canadian provinces? A retrospective cohort study.

TAZ downregulated ANXA1 expression to modulate myeloma cell interactions with bone marrow mesenchymal stromal cells.

Use of implementation mapping to develop a multifaceted implementation strategy for an electronic prospective surveillance model for cancer rehabilitation

Implementation of an electronic prospective surveillance model for cancer rehabilitation: a mixed methods study protocol

Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis.

MST1 downregulates TAZ tumor suppressor protein in multiple myeloma and is a potential therapeutic target.

TAZ upregulates MIR-224 to inhibit oxidative stress response in multiple myeloma.

Exosomal miRNA Profiling for Molecular Classification of Resorptive Bone Disease Progression

CIHR SPOR Mentorship Chair in Innovative Cancer Clinical Trials

Frequent collaborators

Tony Reiman

Gillian Strudwick

Robin Urquhart

Sarah Neil-Sztramko

John Kuruvilla

Cynthia Kendell

Eva Grunfeld

Ralph Meyer

Audrey Durand

Arleigh McCurdy

Martha Louzada

Thomas Pulinilkunnil

Sudeep Shivakumar

Kevin Imrie

Paul Kershaw

Donna Reece

David Lebrun

Tom Kouroukis

Lindsay Mclaren

David Spaner